Adenoid cystic carcinoma of the cervix uteri

Adenoid cystic carcinoma of the cervix uteri is an extremely rare malignant tumor arising from the uterine cervix. This neoplasm is histologically similar to adenoid cystic carcinomas found in salivary glands, characterized by distinctive cribriform (sieve-like), tubular, or solid growth patterns. It accounts for fewer than 1% of all cervical carcinomas and predominantly affects the female reproductive system, though it has a propensity for perineural invasion and can metastasize to distant sites including the lungs, bones, and lymph nodes. Patients typically present with abnormal vaginal bleeding, which may be postmenopausal or intermenstrual, pelvic pain, or a cervical mass detected on examination. Some cases are discovered incidentally during routine cervical screening. The disease tends to occur more frequently in postmenopausal women, and some studies have noted a higher incidence among women of African descent. The tumor is generally considered aggressive, with a tendency for local recurrence and distant metastasis even after treatment. Treatment typically involves a multimodal approach. Radical hysterectomy with pelvic lymph node dissection is the primary surgical treatment for early-stage disease. Adjuvant radiation therapy is frequently employed, particularly in cases with adverse pathological features such as positive margins or lymph node involvement. Chemotherapy may be considered for advanced or recurrent disease, though evidence for its efficacy in this specific tumor type is limited due to the rarity of the condition. Prognosis varies depending on the stage at diagnosis, but overall outcomes tend to be less favorable compared to more common types of cervical cancer, with high rates of recurrence reported in the literature.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Adenoid cystic carcinoma of the cervix uteri